Alzheimer drugs halted

Savings to go to Alzheimer care services

29 June 2018 07:54

By Connexion journalist

Four Alzheimer drugs costing the health service €90million a year will no longer be reimbursed as the ministry moves to stop them being prescribed due to harmful side effects, which include falls and broken bones.

Savings on Aricept, Ebixa, Exelon, Reminyl and generics will go to Alzheimer care services.

More from Connexion

Are there rules for putting a ‘for sale’ sign on car on French street?

iPhone12 users in France to get free update over ‘electrowave issue’

Flood and heavy rain alerts for parts of south of France on Saturday

Resident or second-home owner in France?

Benefit from our daily digest of headlines and how-to's to help you make the most of life in France

By joining the newsletter, you agree to our Terms & Conditions and Privacy Policy

Woman dies and eight in hospital over suspected botulism in Bordeaux

13 September 2023

Graph shows ongoing rises in Covid cases in France

14 September 2023

Irish teacher cannot teach in French schools as failed English test

11 September 2023

Easyjet summer tickets, TGV line delay: 8 French travel updates

15 September 2023

Maison de Jeanne: The French house with a 550-year history

26 May 2022

See more popular articles

The Connexion Help Guides

Income Tax in France 2023 (for 2022 income)*

Featured Help Guide

- Primarily aimed at Britons, covers pensions, rent, ISAs, shares, savings and interest - but also contains significant general information pertinent to readers of other nationalities - Overview of online declarations + step-by-step guide to the French printed forms - Includes updates given automatically after this year's site opened

Income Tax in France 2023 (for 2022 income)*

Visa and residency cards for France*

Alzheimer drugs halted

Savings to go to Alzheimer care services

Income Tax in France 2023

Inheritance Law and Wills in France

Visa and residency cards for France